Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2011 1
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Results by year

Filters applied: . Clear all
Your search was processed without automatic term mapping because it retrieved zero results.
The following term was not found in PubMed: /
Page 1
Pharmacovigilance Analysis of Azelastine-Related Adverse Events: Insights from the FDA FAERS Database (2006-2024).
Liang F, Chen L, Hu C, Lu R, He C, Yu G. Liang F, et al. Curr Drug Saf. 2026 Jun 2. doi: 10.2174/0115748863416393260406204526. Online ahead of print. Curr Drug Saf. 2026. PMID: 42253253
BACKGROUND: Azelastine is widely used in the treatment of allergic rhinitis, and it is necessary to gain insight into the true extent of adverse events (AEs) associated with it. ...Pharmacovigilance departments should maintain vigilance for rare but serious adverse reactio …
BACKGROUND: Azelastine is widely used in the treatment of allergic rhinitis, and it is necessary to gain insight into the true extent …
Two-week comparison study of olopatadine hydrochloride nasal spray 0.6% versus azelastine hydrochloride nasal spray 0.1% in patients with vasomotor rhinitis.
Lieberman P, Meltzer EO, LaForce CF, Darter AL, Tort MJ. Lieberman P, et al. Allergy Asthma Proc. 2011 Mar-Apr;32(2):151-8. doi: 10.2500/aap.2011.32.3439. Epub 2011 Feb 23. Allergy Asthma Proc. 2011. PMID: 21352639 Clinical Trial.
Olopatadine hydrochloride nasal spray 0.6% (OLO) and azelastine nasal spray 137 micrograms (AZE) are effective in treating allergic rhinitis and AZE is indicated for nonallergic vasomotor rhinitis (VMR). ...Overall, 22 and 20 AEs were reported in the OLO and AZE groups, re …
Olopatadine hydrochloride nasal spray 0.6% (OLO) and azelastine nasal spray 137 micrograms (AZE) are effective in treating allergic r …
Effects of olopatadine hydrochloride nasal spray 0.6% in the treatment of seasonal allergic rhinitis: a phase III, multicenter, randomized, double-blind, active- and placebo-controlled study in adolescents and adults.
Shah SR, Nayak A, Ratner P, Roland P, Michael Wall G. Shah SR, et al. Clin Ther. 2009 Jan;31(1):99-107. doi: 10.1016/j.clinthera.2009.01.016. Clin Ther. 2009. PMID: 19243710 Clinical Trial.
OBJECTIVE: The aim of this study was to compare the efficacy and tolerability of olopatadine hydrochloride nasal spray 0.6% (OLO) relative to azelastine hydrochloride nasal spray 0.1% (AZE) and an inactive vehicle in the treatment of SAR. ...The most commonly reported trea …
OBJECTIVE: The aim of this study was to compare the efficacy and tolerability of olopatadine hydrochloride nasal spray 0.6% (OLO) relative t …